Design, synthesis, biological evaluation, and X‐ray single crystal structure of novel computer‐aided‐drug‐designbased α‐mangostin derivatives: Multifunctional ligands against Alzheimer's disease
Archiv der Pharmazie · 2025
DOI: 10.1002/ardp.202400671 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archiv der Pharmazie, 2025. Verfasst von Quanzhen Chen und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Chinese Materia Medica, Tianjin University of Traditional Chinese Medicine, Tianjin, China. Hauptthemen laut MEDLINE: Xanthones, Alzheimer Disease, Drug Design, Cholinesterase Inhibitors. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: Integrated Traditional Chinese and Western Medicine Project of Tianjin Municipal Health and Health Committee, China, National Natural Science Foundation of China.
Themen: Demenz
Abstract (Originalsprache)
Multifunctional ligand design strategy may be a promising approach for the treatment of Alzheimer's disease (AD). α‐Mangostin (α‐M), a natural small molecule with anti‐AD properties, was used as the lead compound for the design and synthesis of six α‐M derivatives ( 1–6 ) with the help of computer‐aided‐drug‐design (CADD). Both theoretical calculations and experimental results suggested that 1–6 might serve as promising selective butyrylcholinesterase (BuChE) inhibitors and amyloid‐β (Aβ) aggregation inhibitors. Meanwhile, experimental results confirmed the high selectivity of the derivatives, in which 1 had the best inhibitory activity and selectivity on BuChE (IC 50 = 0.016 µM, SI = 700.63). The experimental results also showed that 1–6 could act as copper chelators and reactive oxygen species (ROS) scavengers. Furthermore, in vivo experiments with Caenorhabditis elegans also showed that 1 could scavenge ROS and inhibit Aβ aggregation. Notably, single crystals of 1 , 4 , and the 4 ‐Cu(II) complex were prepared for the first time, which provided a reliable structural basis for analyzing the structure–activity relationship. The dimethylamino derivatives ( 1 , 4 ) of α‐M showed the best activities and were expected to become promising candidate drugs for multifunctional anti‐AD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Chinese Materia Medica, Tianjin University of Traditional Chinese Medicine, Tianjin, China.
- Tianjin Key Laboratory of Therapeutic Substance of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, China.
Förderung
- Integrated Traditional Chinese and Western Medicine Project of Tianjin Municipal Health and Health Committee, China
- National Natural Science Foundation of China
Zitieren
APA
Chen, Q., Li, X., Xiao, W., Sun, Y., Shen, R., Kou, X., & Yang, A. (2025). Design, synthesis, biological evaluation, and X‐ray single crystal structure of novel computer‐aided‐drug‐designbased α‐mangostin derivatives: Multifunctional ligands against Alzheimer's disease. Archiv der Pharmazie. https://doi.org/10.1002/ardp.202400671
Vancouver
Chen Q, Li X, Xiao W, Sun Y, Shen R, Kou X, et al. Design, synthesis, biological evaluation, and X‐ray single crystal structure of novel computer‐aided‐drug‐designbased α‐mangostin derivatives: Multifunctional ligands against Alzheimer's disease. Archiv der Pharmazie. 2025. doi:10.1002/ardp.202400671
BibTeX
@article{Chen2025,
author = {Chen, Quanzhen and Li, Xiangyu and Xiao, Wenting and Sun, Yiyi and Shen, Rui and Kou, Xiaodi and Yang, Aihong},
title = {Design, synthesis, biological evaluation, and X‐ray single crystal structure of novel computer‐aided‐drug‐designbased α‐mangostin derivatives: Multifunctional ligands against Alzheimer's disease},
journal = {Archiv der Pharmazie},
year = {2025},
doi = {10.1002/ardp.202400671}
}
EUVIMED